Skip to main content
. 2023 Oct 21;15(10):e47444. doi: 10.7759/cureus.47444

Figure 1. Timeline of antithrombotic treatment after left atrial appendage occlusion with the WATCHMAN™ device based on bleeding risk as recommended by the EHRA/EAPCI consensus statement.

Figure 1

EHRA, European Heart Rhythm Association; EAPCI, European Association of Percutaneous Coronary Interventions